Clinical Trials Browser

Has results × Bortezomib × Breast × Clear all

NCT01142401 2023-11-27

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Phase 2 Completed

118 enrolled 11 charts

Breast Neoplasms

NCT00574236 2019-12-13

Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer

Phase 2 Terminated

4 enrolled 6 charts

Breast Neoplasms